BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35203570)

  • 21. Capability of ganglioside GM1 in modulating interactions, structure, location and dynamics of peptides/proteins: biophysical approaches: interaction of ganglioside GM1 with peptides/proteins.
    Khatun UL; Gayen A; Mukhopadhyay C
    Glycoconj J; 2014 Oct; 31(6-7):435-47. PubMed ID: 25178424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium-ganglioside interactions and synaptic plasticity: effect of calcium on specific ganglioside/peptide (valinomycin, gramicidin A)-complexes in mixed mono- and bilayers.
    Rahmann H; Schifferer F; Beitinger H
    Neurochem Int; 1992 Apr; 20(3):323-38. PubMed ID: 1284679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the ganglioside lipid moiety in the process of ganglioside-cell interactions.
    Bassi R; Sonnino S
    Chem Phys Lipids; 1992 Jul; 62(1):1-9. PubMed ID: 1423800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.
    Ariga T; McDonald MP; Yu RK
    J Lipid Res; 2008 Jun; 49(6):1157-75. PubMed ID: 18334715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.
    Mirkin BL; Clark SH; Zhang C
    Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroimmunology of gangliosides in human neurons and glial cells in culture.
    Kim SU; Moretto G; Lee V; Yu RK
    J Neurosci Res; 1986; 15(3):303-21. PubMed ID: 3701884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gangliosides in neural stem cell fate determination and nerve cell specification--preparation and administration.
    Itokazu Y; Ariga T; Fuchigami T; Li D
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Action of Arthrobacter ureafaciens sialidase on sialoglycolipid substrates. Mode of action and highly specific recognition of the oligosaccharide moiety of ganglioside GM1.
    Saito M; Sugano K; Nagai Y
    J Biol Chem; 1979 Aug; 254(16):7845-54. PubMed ID: 468792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of membrane gangliosides in the binding and action of bacterial toxins.
    Fishman PH
    J Membr Biol; 1982; 69(2):85-97. PubMed ID: 6752418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gangliosides of the Nervous System.
    Ledeen R; Wu G
    Methods Mol Biol; 2018; 1804():19-55. PubMed ID: 29926403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.
    Asthana P; Vong JS; Kumar G; Chang RC; Zhang G; Sheikh KA; Ma CH
    Mol Neurobiol; 2016 Sep; 53(7):4981-91. PubMed ID: 26374552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells.
    Chiricozzi E; Pomè DY; Maggioni M; Di Biase E; Parravicini C; Palazzolo L; Loberto N; Eberini I; Sonnino S
    J Neurochem; 2017 Dec; 143(6):645-659. PubMed ID: 28796418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Therapeutic Role of Gangliosides in Neurological Disorders.
    Schneider JS
    CNS Drugs; 1994 Mar; 1(3):213-22. PubMed ID: 27520520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of GM1 ganglioside with crude rat brain neuronal membranes.
    Toffano G; Benvegnù D; Bonetti AC; Facci L; Leon A; Orlando P; Ghidoni R; Tettamanti G
    J Neurochem; 1980 Oct; 35(4):861-6. PubMed ID: 7452294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro.
    Paparounas K; O'Hanlon GM; O'Leary CP; Rowan EG; Willison HJ
    Brain; 1999 May; 122 ( Pt 5)():807-16. PubMed ID: 10355667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.
    Sipione S; Monyror J; Galleguillos D; Steinberg N; Kadam V
    Front Neurosci; 2020; 14():572965. PubMed ID: 33117120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome.
    Willison HJ; O'Hanlon G; Paterson G; O'Leary CP; Veitch J; Wilson G; Roberts M; Tang T; Vincent A
    J Infect Dis; 1997 Dec; 176 Suppl 2():S144-9. PubMed ID: 9396699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.